Admin-Core

管理核心

基本信息

批准号：
10006540
负责人：
VICTORIA L. SEEWALDT
金额：
$ 3.41万
依托单位：
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-02 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10006540
关键词：
Achievement Address African American African American student Antelopes Asians California Cancer Center Support Grant Cancer Death Rates Cell Line Cellular biology Chicago City of Hope Comprehensive Cancer Center Clinical Trials Communities Conduct Clinical Trials Data Developmental Therapeutics Program Doctor of Medicine Doctor of Philosophy Documentation Ensure European Evaluation Faculty Funding Goals Grant Health Health Sciences Healthcare Hispanics Housing Illinois Joints K-Series Research Career Programs Latino Lead Leadership Logistics Minority Mission Monitor National Cancer Institute Not Hispanic or Latino Physicians Pilot Projects Policies Policy Developments Politics Postdoctoral Fellow Principal Investigator Publications Reporting Research Research Personnel Resources Safety Science Scientist Site Testing Therapeutic Time TimeLine Toxicology Training Translational Research Underrepresented Minority Universities anticancer research cancer health disparity clinical trial participant drug development drug discovery education research health disparity human subject protection improved meetings member minority communities novel therapeutics professor programs stem cells success translational research program

项目摘要

ABSTRACT The mission of the Administrative Core is to facilitate the capacity building and training mission of the University of California Riverside (UCR) - City of Hope Comprehensive Cancer Center (CoH-CCC) P20 Program. Both UCR and CoH-CCC are committed to providing the P20 PIs and investigators with necessary resources including protected time and clerical assistance. The Administrative Core will provide scientific leadership, administration, and fiscal management. The Core will be led by P20 PI's, Ernest Martinez, Ph.D. (UCR) and Victoria Seewaldt, M.D. (CoH). The P20 PI's are both R01 funded and are committed to training of underrepresented minorities. External Advisory Board (EAB) and Internal Advisory Board (IAB) will help guide our P20 planning, implementation, and evaluation. Together, we will develop initial plans, set priorities, and implement and evaluate whether we meet our P20 goals and milestones. Our EAB leaders are well-qualified to guide our P20 Partnership. EAB members are world leaders in the health science of disparities and lead their own P20 and U54 grants. EAB members include: Elana Martinez, Ph.D. (UC San Diego), Lucio Miele, M.D. (LSU), Ricardo Richardson, Ph.D. (NCCU), and Robert Winn, M.D. (University of Illinois, Chicago). EAB leaders will meet on site yearly to evaluate progress of the P20. Our IAB members are senior leaders within UCR and CoH-CCC. UCR IAB members include: Dr. Kelechi Kalu, Ph.D., Vice Provost and Professor of Political Science and Dr. Frances Sladek, Professor of Cell Biology and Toxicology. CoH-CCC IAB leaders include David Horne, Ph.D., CoH-CCC Developmental Therapeutics Program and Beckman Therapeutic Director and Linda Malkas, Ph.D., Dean of Translational Science and External Affairs CoH-CCC and Board of Directors California Stem Cell Translational Research Program. IAB and P20 leaders will meet quarterly, or more frequently if needed, to provide strategic direction, policy development, and evaluation of our P20 Partnership Project.

抽象的行政核心的任务是促进能力建设和培训任务加州大学河滨大学（UCR） - 希望之城综合癌症中心（COH -CCC）P20 程序。 UCR和COH-CCC都致力于向P20 PI和调查人员提供必要的包括受保护时间和文书协助的资源。行政核心将提供科学领导，管理和财政管理。核心将由P20 PI的Ernest Martinez博士领导。（UCR）和M.D.的Victoria Seewaldt（COH）。 P20 PI均为R01资助，并致力于培训代表性不足的少数民族。外部顾问委员会（EAB）和内部顾问委员会（IAB）将帮助指导我们的P20计划，实施和评估。我们将共同制定初始计划，设定优先级并实施，并评估我们是否符合P20目标和里程碑。我们的EAB领导者资格地指导我们的P20合作伙伴关系。 EAB成员是世界领导人差异的健康科学，领导自己的P20和U54赠款。 EAB成员包括：Elana 马丁内斯博士（加州大学圣地亚哥加州大学），医学博士Lucio Miele（LSU），Ricardo Richardson，博士（NCCU）和罗伯特医学博士Winn（伊利诺伊大学，芝加哥大学）。 EAB领导人每年将在现场开会，以评估 P20。我们的IAB成员是UCR和COH-CCC中的高级领导者。 UCR IAB成员包括：博士 Kelechi Kalu博士，政治学副教务长兼教授和牢房教授Frances Sladek博士生物学和毒理学。 COH-CCC IAB领导者包括David Horne博士，COH-CCC发展 Therapeutics计划和Beckman治疗总监和Linda Malkas，Ph.D. 科学与外部事务COH-CCC和董事会加利福尼亚干细胞翻译研究程序。 IAB和P20领导者将每季度或在需要时更频繁地开会，以提供战略方向，政策制定和我们P20合作伙伴项目的评估。